secwatch.observer — SEC 8-K summary
======================================

Issuer:     KYNTRA BIO, INC. (KYNB)
CIK:        0000921299
Form:       8-K
Filed at:   2026-06-15T23:23:08+00:00
Accession:  0001193125-26-271449
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Kyntra Bio: Michael Kauffman elected Class III director with 96% vote; exec comp, auditor ratified
--------------------------------------------------------------------------------

- Michael Kauffman, M.D., Ph.D., elected Class III director with 1,239,169 votes for (96.04%), 0 against, 51,081 withheld.
- Advisory vote on executive compensation approved: 1,242,005 for, 23,606 against, 24,639 abstain.
- Ratification of PricewaterhouseCoopers as auditor for FY 2026: 2,712,825 for, 14,392 against, 7,461 abstain.
- Broker non-votes totaled 1,444,428 on director election and say-on-pay proposals.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/921299/000119312526271449/0001193125-26-271449-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/921299/000119312526271449/kynb-20260612.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-271449

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer